Lars Birkmann
Director of Finance/CFO bei ACHIKO AG
Profil
Lars Birkmann is currently the Chief Financial Officer at Achiko AG since 2022.
Prior to this, he worked as the Chief Financial Officer at Ender Diagnostics AG.
Aktive Positionen von Lars Birkmann
Unternehmen | Position | Beginn |
---|---|---|
ACHIKO AG | Director of Finance/CFO | 05.10.2022 |
Ehemalige bekannte Positionen von Lars Birkmann
Unternehmen | Position | Ende |
---|---|---|
Ender Diagnostics AG
Ender Diagnostics AG Medical SpecialtiesHealth Technology Ender Diagnostics AG is a Swiss private company that specializes in developing molecular diagnostic test kits for the rapid and reliable detection of SARS-CoV-2, the virus that causes COVID-19. The company has its headquarters in Bern, CH, and a subsidiary with offices in the US. The team at Ender Diagnostics has extensive experience in developing molecular biological rapid tests for infectious diseases. The company is supported by several private investors with know-how and financing. Ender Diagnostics was founded in 2019, and the CEO is Paul Senn. | Director of Finance/CFO | - |
Erfahrungen
Besetzte Positionen
Aktive
Inaktive
Börsennotierte Unternehmen
Private Unternehmen
Beziehungen
Beziehungen ersten Grades
Unternehmen ersten Grades
Herr
Frau
Aufsichtsräte
Führungskräfte
Unternehmensverbindungen
Börsennotierte Unternehmen | 1 |
---|---|
ACHIKO AG | Technology Services |
Private Unternehmen | 1 |
---|---|
Ender Diagnostics AG
Ender Diagnostics AG Medical SpecialtiesHealth Technology Ender Diagnostics AG is a Swiss private company that specializes in developing molecular diagnostic test kits for the rapid and reliable detection of SARS-CoV-2, the virus that causes COVID-19. The company has its headquarters in Bern, CH, and a subsidiary with offices in the US. The team at Ender Diagnostics has extensive experience in developing molecular biological rapid tests for infectious diseases. The company is supported by several private investors with know-how and financing. Ender Diagnostics was founded in 2019, and the CEO is Paul Senn. | Health Technology |